Medusa Medical Technologies

About:

Medusa Medical Technologies develops information technology solutions for the pre-hospital emergency services industry.

Website: http://www.medusamedical.com

Twitter/X: MedusaMatte

Top Investors: Medtronic, Innovacorp, Canadian International Capital, Technology Venture Corporation, Atlantic Innovation Fund

Description:

Medusa revolutionized EMS patient care documentation in the late 1990's with the introduction of Siren ePCR Suite. Today, they continue to drive ePCR technology to improve patient care with innovative solutions like hospital notification systems and real-time data communications. Siren is a complete software solution that enables paramedics to chart patient care and share information in real-time, easily manage ePCR workflow and analyze patient data. Ultimately, Siren helps agencies realize significant clinical and operational benefits to improve performance and quality.

Total Funding Amount:

$7.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Halifax, Nova Scotia, Canada

Founded Date:

1996-01-01

Founders:

Christopher McNamara

Number of Employees:

51-100

Last Funding Date:

2013-06-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai